Evaluation of the residual solvent content of counterfeit tablets and capsules

Journal of Pharmaceutical and Biomedical Analysis

Volumn 81-82, Issue , 2013, Pages 80-88

  Deconinck, E ^a   Canfyn, M ^a   Sacre P Y ^a,b   Courselle, P ^a   De Beer, J O ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Counterfeit medicines; Gas chromatography; Mass spectrometry; Residual solvents; Secondary components

Indexed keywords

2 PROPANOL; ACETIC ACID ETHYL ESTER; ACETONE; ALCOHOL; BENZENE; CARBON TETRACHLORIDE; CHLOROFORM; COUNTERFEIT DRUG; DICHLOROMETHANE; ETHYLBENZENE; SILDENAFIL; SOLVENT; TADALAFIL; TOLUENE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); DRUG CAPSULE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; STANDARD; TABLET FORMULATION;

CAPSULES; CARBOLINES; COUNTERFEIT DRUGS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GUIDELINES AS TOPIC; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; SOLVENTS; SULFONES; TABLETS;

EID: 84877070883     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.03.023     Document Type: Article

References (38)

1. Weiss A. Buying prescription drugs on the internet: promises and pitfalls. Cleve. Clin. J. Med. 2006, 73:282-288.
2. Veronin M., Youan B.B. Magic bullet gone astray: medications and the internet. Science 2004, 305:481.
3. European alliance for access to safe medicines: http://www.eaasm.eu/.
4. WHO, sixty-second world health assembly item 12.9, counterfeit medical products, April 2009. http://aps.who.int/gb/ebhwa/pdf_files/A62/A62_13-en.pdf.
5. Vredenbregt M.J., Blok-Tip L., Hoogerbrugge R., Barends D.M., de Kaste D. Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopy. J. Pharm. Biomed. Anal. 2006, 40:840-849.
6. Reddy T.S., Reddy A.S., Devi P. Quantitative determination of sildenafil citrate in herbal medicinal formulations by high-performance thin-layer chromatography. J. Planar Chromatogr. Mod. TLC 2006, 19:427-431.
7. Reepmeyer J., Woodruff J.J. Use of liquid chromatography-mass spectrometry and a chemical cleavage reaction for the structure elucidation of a new sildenafil analogue detected as an adulterant in an herbal dietary supplement. J. Pharm. Biomed. Anal. 2007, 44:887-893.
8. Reepmeyer J., André d'Avignon D. Structure elucidation of thioketone analogues of sildenafil detected as adulterants in herbal aphrodisiacs. J. Pharm. Biomed. Anal. 2009, 49:145-150.
9. Gratz S., Zeller M., Mincey D., Flurer C. Structural characterization of sulfoaildenafil, an analogue of sildenafil. J. Pharm. Biomed. Anal. 2009, 50:228-231.
10. Reepmeyer J., Woodruff J. Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a "natural" herbal dietary supplement. J. Chromatogr. A 2006, 1125:67-75.
11. Lam Y.H., Poon W.T., Lai C.K., Chan A.Y.W., Mak T.W.L. Identification of a novel vardenafil analogue in herbal product. J. Pharm. Biomed. Anal. 2008, 46:804-807.
12. Ge X., Low M.-Y., Zou P., Lin L., Yin S.O.S., Bloodworth B.C., Koh H.L. Structural elucidation of a PDE-5 inhibitor detected as an adulterant in a health supplement. J. Pharm. Biomed. Anal. 2008, 48:1070-1075.
13. Park H.J., Jeong H.K., Chang M.I., Im M.H., Jeong J.Y., Choi D.M., Park K.K., Hong M.K., Youm J., Han S.B., Kim D.J., Park J.H., Kwon S.W. Structure determination of new analogues of vardenafil and sildenafil in dietary supplements. Food Addit. Contam. 2007, 24:122-129.
14. Blok-Tip L., Zomer B., Bakker F., Hartog K.D., Hamzink M., ten Hove J., Vredenbregt M., de Kaste D. Structure elucidation of sildenafil analogues in herbal products. Food Addit. Contam. 2004, 21:737-748.
15. Zou P., Hou P., Oh S.S.Y., Chong Y.M., Bloodworth B.C., Low M.Y., Koh H.L. Isolation and identification of thiohomosildenafiland and thiosildenafil in health supplements. J. Pharm. Biomed. Anal. 2008, 47:279-284.
16. Venhuis B.J., Zomer G., de Kaste D. Structure elucidation of a novel synthetic thiono analogue of sildenafil detected in an alleged herbal aphrodisiac. J. Pharm. Biomed. Anal. 2008, 46:814-817.
17. Venhuis B.J., Zomer G., Hamzink M., Meiring H.D., Aubin Y., de Kaste D. The identification of a nitrosated prodrug of the PDE-5 inhibitor aildenafil in a dietary supplement: a Viagra with a pop. J. Pharm. Biomed. Anal. 2011, 54:735-741.
18. ® and the optical purity of tadalafil stereoisomers. J. Pharm. Biomed. Anal. 2010, 51:723-727.
19. Häberli A., Girard P., Low M.Y., Ge X. Isolation and structure elucidation of an interaction product of aminotadalafil found in an illegal health food product. J. Pharm. Biomed. Anal. 2010, 53:24-28.
20. Lee H.M., Kim C.S., Jang Y.M., Kwon S.W., Lee B.J. Separation and structural elucidation of a novel analogue of vardenafil included as an adulterant in a dietary supplement by liquid chromatography-electrospray ionization mass spectrometry, infrared spectroscopy and nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 2011, 54:491-496.
21. Sacré P.-Y., Deconinck E., De Beer T., Courselle P., Vancauwenberghe R., Chiap P., Crommen J., De Beer J.O. Comparison and combination of spectroscopic techniques for the detection of counterfeit medicines. J. Pharm. Biomed. Anal. 2010, 53:445-453.
22. de Veij M., Deneckere A., Vandenabeele P., de Kaste D., Moens L. Detection of counterfeit Viagra with Raman spectroscopy. J. Pharm. Biomed. Anal. 2008, 46:303-309.
23. 1H NMR and Raman spectroscopy. J. Pharm. Biomed. Anal. 2008, 47:103-113.
24. Maurin J.K., Pluciński F., Mazurek A.P., Fijałek Z. The usefulness of simple X-ray powder diffraction analysis for counterfeit control - the Viagra example. J. Pharm. Biomed. Anal. 2007, 43:1514-1518.
25. Amin A.S., Moustafa M.E., El-Dosoky R. Colorimetric determination of sildenafil citrate (Viagra) through ion-associate complex formation. J. AOAC Int. 2009, 92:125-130.
26. Rodomonte A.L., Gaudiano M.C., Antoniella E., Lucente D., Crusco V., Bartolomei M., Bertocchi P., Manna L., Valvo L., Muleri N. Counterfeit drugs detection by measurement of tablets and secondary packaging colour. J. Pharm. Biomed. Anal. 2010, 53:215-220.
27. 15N NMR analysis of sildenafil base and citrate (Viagra) in solution, solid state and pharmaceutical dosage forms. J. Pharm. Biomed. Anal. 2005, 38:865-870.
28. International Conference on Harmonisation (ICH) of technical requirements for the registration of pharmaceuticals for human use, Q3C: impurities: guidelines for residual solvents, Step 4 (1997).
29. United States Pharmacopoeia 35 United States Pharmacopeial 2010, Convention, Inc., Rockville, MD, USA.
30. European Pharmacopoeia 7.0 Council of Europe 2010, Strasbourg, France.
31. Japanese Pharmacopoeia 2011, Society of Japanese Pharmacopoeia, Tokyo. 16th ed.
32. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., De Jong S., Lewi P.J., Smeyers-Verbeke J. Handbook of Chemometrics and Qualimetrics - Part A 1997, Elsevier Science, Amsterdam.
33. Croux C., Ruiz-Gazen C. A COMPSTAT: Proceedings in Computational Statistiques 1996, Physica-Verlag, Heidelberg.
34. Kichhoff M.M. Promoting sustainability through green chemistry. Resour. Conserv. Recycl. 2005, 44:237-243.
35. European patent: a process for the preparation of tadalafil, EP2181997 A1, publication date 5 May 2010.
36. Deconinck E., Canfyn M., Sacré P.-Y., Baudewyns S., Courselle P., De Beer J.O. A validated GC-MS method for the determination and quantification of residual solvents in counterfeit tablets and capsules. J. Pharm. Biomed. Anal. 2012, 70:64-70.
37. European patent: Methods for the production of sildenafil bas and citrate salt, EP 1633364 A2, publication date 15 March 2005.
38. Xiao S., Shi X., Xing J., Yan J., Liu S., Lu W. Synthesis of tadalafil (Cialis) drim l-tryptophan. Tetrahedron: Asymmetry 2009, 20:2090-2096.